Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device Post author:Sam Post published:August 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like GlaxoSmithKline Ditches Ionis Pharma's Inotersen and IONIS-FB-LRx August 10, 2017 Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions May 23, 2017 Senseonics Prices $41 Million Underwritten Offering of Common Stock May 25, 2017
Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions May 23, 2017